Newer Glucagon-Like Peptide-1 Receptor Agonists Are Associated With Improved Glycemic Control in US Adults With Type 2 Diabetes: A Population-Level Time Series Analysis.
Saved in:
| Title: | Newer Glucagon-Like Peptide-1 Receptor Agonists Are Associated With Improved Glycemic Control in US Adults With Type 2 Diabetes: A Population-Level Time Series Analysis. |
|---|---|
| Authors: | Lv L; Novo Nordisk Inc, Plainsboro, NJ, USA. Electronic address: lzlv@novonordisk.com., Wang Y; Analysis Group, Inc, Los Angeles, CA, USA., Xie L; Novo Nordisk Inc, Plainsboro, NJ, USA., Noone J; Novo Nordisk Inc, Plainsboro, NJ, USA., Alvarez S; Novo Nordisk Inc, Plainsboro, NJ, USA., Zhang Y; Analysis Group, Inc, New York, NY, USA., Song Y; Analysis Group, Inc, Boston, MA, USA., Rotroff DM; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Center for Quantitative Metabolic Research, Cleveland Clinic, Cleveland, OH, USA; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA. |
| Source: | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2025 May; Vol. 28 (5), pp. 712-719. Date of Electronic Publication: 2025 Feb 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1524-4733 |
|---|---|
| DOI: | 10.1016/j.jval.2025.01.018 |
